- Home
- ADN vs SNOA Comparison
ADN vs SNOA Comparison
Compare ADN & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADN
- SNOA
- Stock Information
- Founded
- ADN 2006
- SNOA 1999
- Country
- ADN United States
- SNOA United States
- Employees
- ADN N/A
- SNOA N/A
- Industry
- ADN Power Generation
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- ADN Utilities
- SNOA Health Care
- Exchange
- ADN Nasdaq
- SNOA Nasdaq
- Market Cap
- ADN 6.6M
- SNOA 6.4M
- IPO Year
- ADN N/A
- SNOA 2007
- Fundamental
- Price
- ADN $2.90
- SNOA $3.32
- Analyst Decision
- ADN
- SNOA
- Analyst Count
- ADN 0
- SNOA 0
- Target Price
- ADN N/A
- SNOA N/A
- AVG Volume (30 Days)
- ADN 23.4K
- SNOA 60.2K
- Earning Date
- ADN 12-27-2024
- SNOA 06-16-2025
- Dividend Yield
- ADN N/A
- SNOA N/A
- EPS Growth
- ADN N/A
- SNOA N/A
- EPS
- ADN N/A
- SNOA N/A
- Revenue
- ADN $3,276,000.00
- SNOA $13,973,000.00
- Revenue This Year
- ADN $2,232.99
- SNOA $23.89
- Revenue Next Year
- ADN $91.56
- SNOA $25.45
- P/E Ratio
- ADN N/A
- SNOA N/A
- Revenue Growth
- ADN 274.35
- SNOA 13.51
- 52 Week Low
- ADN $1.71
- SNOA $1.75
- 52 Week High
- ADN $8.79
- SNOA $9.37
- Technical
- Relative Strength Index (RSI)
- ADN 55.41
- SNOA 52.15
- Support Level
- ADN $2.52
- SNOA $3.05
- Resistance Level
- ADN $2.74
- SNOA $3.60
- Average True Range (ATR)
- ADN 0.26
- SNOA 0.19
- MACD
- ADN 0.07
- SNOA -0.01
- Stochastic Oscillator
- ADN 84.51
- SNOA 49.09
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.